Experiences and preferences towards collecting a urine and cervicovaginal self-sample among women attending a colposcopy clinic
Schaafsma et al.
The finding, in our words
Women reported that urine collection was more acceptable than cervicovaginal self sampling, and most found the instructions clear, supporting the use of home based urine self collection to improve participation in cervical screening.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.
In a Belgian colposcopy referral cohort, a study found that 66.6% of women preferred home-based first-void urine self-sampling over physician-taken samples, and 96.6% found the Colli-Pee UCM FV-5010 device easy to use. This supports patient-centric, decentralised screening, though results are limited to this specific referral population.
Hendrickx et al., Archives of public health = Archives belges de sante publique · source ↗
Urine testing for high-risk HPV achieved 86.2% sensitivity for detecting high-grade cervical lesions, slightly below the 94.8% sensitivity of cervical samples, while patient satisfaction was significantly higher with self-collected urine. High agreement for HPV 16/18 genotypes between the two methods supports urine as a viable alternative for decentralised cervical screening.
Punyashthira et al., The journal of obstetrics and gynaecology research (paywalled) · source ↗
Urine self-sampling for HPV detection showed good agreement with clinician-collected cervical samples (Kappa 0.72) under optimised conditions of 40 mM EDTA preservative, storage at 25°C, and processing within 72 hours. With a cost of USD 1.10 and high acceptability among women and healthcare workers, this method offers a practical decentralised screening approach for resource-limited settings.
A study of 2500 women found 99.0% agreement between first-void urine and vaginal self-sampling for HPV detection using Cobas4800, with 98.1% of participants preferring urine. Although conducted in a resource-limited setting which may limit generalisability, these results support urine as a viable sample type for decentralised, patient-centric screening.
First-void urine and self-collected vaginal swabs showed similar sensitivity and specificity to clinician-collected cervical samples for high-risk HPV detection across two real-time PCR assays, supporting their use as decentralised, patient-collected alternatives; most women preferred first-void urine for regular cervical screening.
A et al., Journal of gynecologic oncology (paywalled) · source ↗